AP NEWS
Press release content from Business Wire. The AP news staff was not involved in its creation.
PRESS RELEASE: Paid content from Business Wire
Press release content from Business Wire. The AP news staff was not involved in its creation.

North American Cartilage Repair Market Outlook to 2024 - Projected to Grow at a CAGR of 7.7% - ResearchAndMarkets.com

February 20, 2019

DUBLIN--(BUSINESS WIRE)--Feb 20, 2019--The “North America Cartilage Repair Market (2018-2024)” report has been added to ResearchAndMarkets.com’s offering.

The North America Cartilage Repair Market is expected to witness market growth of 7.7% CAGR during the forecast period 2018-2024. This market research report covers the analysis of key stake holders of the market.

The market growth of cartilage repair market is primarily attributed to the well-established healthcare infrastructure. Furthermore, the growth in the region is also due to growing awareness about arthritis, and growing investments by the government into healthcare sector.

The tissue prevents friction between the bones, by absorbing shock in the joints. When damage is caused in the cartilage, it restricts the regular movement of the knee, causing immense pain. It generally occurs after a traumatic and twisting injury to the knee. If cartilage damage remains untreated, it is expected to lead to knee replacement surgery.

Topics Covered

Chapter 1. Market Scope & Methodology 1.1 Market Definition 1.2 Objectives 1.3 Market Scope 1.4 Segmentation 1.4.1 North America Cartilage Repair Market, by Modality 1.4.2 North America Cartilage Repair Market, by Treatment type 1.4.3 North America Cartilage Repair Market, by Application 1.4.4 North America Cartilage Repair Market, by Site outlook 1.4.5 North America Cartilage Repair Market, by Country 1.5 Methodology for the research

Chapter 2. Market Overview 2.1 Introduction 2.1.1 Overview 2.1.2 Market Composition and Scenario 2.1.3 Players Outlook for the Market 2.2 Key Factors Impacting the Market 2.2.1 Market Drivers 2.2.2 Market Restraints

Chapter 3. North America Cartilage Repair Market by Modality 3.1.1 North America Cell-Based Market by Country 3.1.1.1 North America Cartilage Repair Market by Cell-Based Type 3.1.1.1.1 North America Chondrocyte Transplantation Market by Country 3.1.1.1.2 North America Growth Factor Technology Market by Country 3.1.2 North America Non-Cell-Based Market by Country 3.1.2.1 North America Cartilage Repair Market by Non-Cell-Based Type 3.1.2.1.1 North America Tissue Scaffolds Market by Country 3.1.2.1.2 North America Cell-Free Composites Market by Country

Chapter 4. North America Cartilage Repair Market by Treatment Type 4.1.1 North America Intrinsic Repair Stimulus Market by Country 4.1.2 North America Palliative Market by Country 4.1.2.1 North America Cartilage Repair Market by Palliative Type 4.1.2.1.1 North America Debridement & Lavage Market by Country 4.1.2.1.2 North America Viscosupplementation Market by Country

Chapter 5. North America Cartilage Repair Market by Application 5.1.1 North America Fibrocartilage Market by Country 5.1.2 North America Hyaline Cartilage Market by Country

Chapter 6. North America Cartilage Repair Market by Site Outlook 6.1.1 North America Knee Cartilage Repair Market by Country 6.1.1.1 North America Cartilage Repair Market by Knee Cartilage Repair Type 6.1.1.1.1 North America Microfracture Market by Country 6.1.1.1.2 North America Arthroscopic Chondroplasty Market by Country 6.1.1.1.3 North America Autologous Chondrocyte Market by Country 6.1.1.1.4 North America Osteochondral Grafts Transplantation Market by Country 6.1.1.1.5 North America Cell-based Cartilage Resurfacing Market by Country 6.1.1.1.6 North America Other Knee Cartilage Repair Type Market by Country 6.1.2 North America Other Site Outlook Market by Country

Chapter 7. North America Cartilage Repair Market by Country 7.1 USA Cartilage Repair Market 7.2 Canada Cartilage Repair Market 7.3 Mexico Cartilage Repair Market 7.4 Rest of North America Cartilage Repair Market

Chapter 8. Company Profiles 8.1 B. Braun Melsungen AG 8.2 Smith & Nephew PLC 8.3 Stryker Corporation 8.4 Johnsons & Johnsons 8.5 Vericel Corporation 8.6 Osiris Therapeutics Inc. 8.7 Collagen solutions PLC 8.8 Arthrex Inc. 8.9 Zimmer Biomet Holdings Inc. 8.10 Anika Therapeutics Inc.

For more information about this report visit https://www.researchandmarkets.com/research/qm9rkh/north_american?w=4

View source version on businesswire.com:https://www.businesswire.com/news/home/20190220005672/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Surgical Procedures

KEYWORD: NORTH AMERICA

INDUSTRY KEYWORD: SURGERY HEALTH

SOURCE: Research and Markets

Copyright Business Wire 2019.

PUB: 02/20/2019 11:18 AM/DISC: 02/20/2019 11:18 AM

http://www.businesswire.com/news/home/20190220005672/en